Dr Melissa Byrne’s PhD focussed on the use of animal models of disease for the translation of basic science into pre-clinical research and in the longer term clinical outcomes. As such she has been involved in the pre-clinical phase of a number of device-based start-up companies which have now progressed to clinical trials, including the Cardiac Dimensions, Sunshine Heart and Osprey Medical. Dr Byrne was awarded a Guidant Industry Fellowship work with Dr David Kass at Johns Hopkins Institute in Baltimore, USA.
Upon returning to Australia, Dr Byrne was invited to take the position of pre-clinical research manager for the Heart Failure Research Group at the BakerIDI Heart and Diabetes Institute. Here, she has been involved in the development of a patented closed circuit infusion system for the delivery of therapeutic agents (genes, drugs) for the treatment of heart failure, and is a named inventor on four provisional US patent applications
Abstracts this author is presenting: